The Recall Desk

Hazard

Infection recalls

2,518 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
2,518
Critical
31
Severe
1,671
Most recent
2026-08-26

Of the 2,518 infection recalls we have scored against our rubric, 31 (1%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,671 (66%) are Severe.

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all infection recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

776–800 of 2518

  • SevereFDA (Drugs)·D-1087-2018·2018-08-22

    Ranier's Compounding Laboratory Recalls Vitamin D3 Injection Due to Sterility Concerns

    Ranier's Compounding Laboratory is recalling Vitamin D3 Injection, 50,000 IU/mL, 4 mL vials, because practices at the firm may call into question the sterility of the product.

    Product
    Vitamin D3 Injection, 50,000 IU/mL, 4 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1085-2018·2018-08-22

    Ranier's Compounding Laboratory Recalls Morphine Sulf Inhalation Due to Sterility Concerns

    Ranier's Compounding Laboratory is recalling 60 vials of Morphine Sulf inhalation because practices at the firm may call into question the sterility of the product.

    Product
    Morphine Sulf inhalation, 5mg/3cc, 3cc per vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1091-2018·2018-08-22

    Ranier's Compounding Laboratory Recalls PRASH Injection Due to Sterility Concerns

    Ranier's Compounding Laboratory is recalling PRASH Injection vials because practices at the firm may call into question the sterility of the product.

    Product
    PRASH 12.2mcg/1.22m/19.29 (Prostaglandin/Phentolamine/Papaverine) Injection, 10 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1093-2018·2018-08-22

    Ranier's Compounding Laboratory Recalls P/P/P Injection Due to Sterility Concerns

    Ranier's Compounding Laboratory is recalling P/P/P Injection vials because practices at the firm may call into question the sterility of the product.

    Product
    P/P/P 0.02/40/2mg/mL(Prostaglandin//Papaverine/Phentolamine) Injection, 0.02/40/2 mg/mL, 1 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1090-2018·2018-08-22

    Ranier's P/P/P Injection Recalled for Sterility Assurance Concerns

    Ranier's Compounding Laboratory is recalling P/P/P Injection vials because practices at the firm may call into question the sterility of the products.

    Product
    P/P/P (Prostaglandin/Papaverine/Phentolamine) Injection, 0.02/30/2 mg/mL, 5 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1084-2018·2018-08-22

    Ranier's PR/PA/PH Injection Recalled for Sterility Concerns

    Ranier's Compounding Laboratory is recalling PR/PA/PH Injection vials due to a lack of assurance of sterility. The product was distributed in Pennsylvania.

    Product
    PR/PA/PH (Prostaglandin/Papaverine/Phentolamine) Injection, 10mcg/30/1mg/mL, 10 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1088-2018·2018-08-22

    Ranier's Medroxprogesterone Ophthalmic Solution Recalled for Sterility Concerns

    Ranier's Compounding Laboratory is recalling Medroxprogesterone 1% Ophthalmic Solution due to a lack of assurance of sterility. The product was distributed in Pennsylvania.

    Product
    Medroxprogesterone 1% Ophthalmic Solution, 10 mL droptainer, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1060-2018·2018-08-15

    Guardian Pharmacy Recalls Magnesium Sulfate Vials Due to Sterility Concerns

    Guardian Pharmacy Services is recalling 1,000 vials of Magnesium Sulfate 200 mg/mL in Texas due to a lack of sterility assurance.

    Product
    Magnesium Sulfate 200 mg/mL, 100ml. Rx. Only. Packaged in 100 mL MDV vials. Compounded Guardian Pharmacy Services, 7920 Elmbrook Dr. Ste. 108C Dallas TX 75247
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1063-2018·2018-08-15

    Guardian Pharmacy Recalls Fentanyl Citrate Syringes Due to Sterility Concerns

    Guardian Pharmacy Services is recalling 300 syringes of Fentanyl Citrate 50 mcg/mL in Texas due to a lack of sterility assurance.

    Product
    Fentanyl Citrate 50 mcg/mL 2ml. Rx Only. Packaged in 2 mL syringes. Compounded Guardian Pharmacy Services, 7920 Elmbrook Dr. Ste. 108C Dallas TX 75247
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0957-2018·2018-07-25

    Avella Recalls Midazolam Syringes Due to Sterility Assurance Concerns

    Avella of Deer Valley, Inc. is recalling 110 syringes of Midazolam 1 mg/mL due to a lack of assurance of sterility and potential bag leakage.

    Product
    Midazolam 1 mg/mL (Midazolam HCL (USP) 55 mg, 0.9% Sodium Chloride, (USP) QS 55 mL) Volume: 55mL. Single dose syringe. Advanced Pharma, 9265 Kirby Dr., Houston TX 77054. NDC 15082-401-76
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Devices)·Z-2443-2018·2018-07-25

    NewDeal UNI-CP Medical Devices Recalled Due to Infection Risk

    NewDeal SA is recalling specific UNI-CP medical devices because their use may cause superficial or deep infections requiring antibiotic treatment or device removal.

    Product
    UNI-CP, Model Numbers: 330021S, 330023S, 330025S, 330030S, 330025S, 30030S, 330217S, 330220S, 330225S, 330230S, 330420S, 330425S, & 330430S
    Category
    Medical Device
    Distribution
    19 states
  • SevereFDA (Drugs)·D-0921-2018·2018-07-25

    La Vita Compounding Pharmacy Recalls Methylcobalamin Injections Due to Sterility Concerns

    La Vita Compounding Pharmacy is recalling Methylcobalamin 1mg/mL Injection vials because production methods raised questions about the sterility of the drug product.

    Product
    Methylcobalamin 1mg/mL Injection w/Pres. (Benzyl Alcohol 1% in Sterile Water), packaged in 10 mL and 30 mL vials, Rx only, la VITA Compounding Pharmacy, 858.453.2500
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0922-2018·2018-07-25

    La Vita Compounding Pharmacy Recalls Methyl Folate Injection Due to Sterility Concerns

    La Vita Compounding Pharmacy is recalling Methyl Folate CA+ 1mg/ml Injection vials because production methods raised questions about the sterility of the drug product.

    Product
    Methyl Folate CA+ 1mg/ml Injection w/Pres. (Benzyl Alcohol 1% in Sterile Water), 10 mL and 30 mL vials, Rx only, la VITA Compounding Pharmacy, 858.453.2500
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0935-2018·2018-07-25

    Avella Recalls Hydromorphone Syringes Due to Sterility Assurance Concerns

    Avella of Deer Valley, Inc. is recalling 275 single-dose hydromorphone syringes nationwide due to a lack of assurance of sterility caused by potential bag leakage.

    Product
    HYDROmorphone 1 mg/mL (HYDROmorphone HCL (USP) 50 mg, 0.9% Sodium Chloride (USP) QS 50 mL) Volume: 50mL. Single dose syringe. Avella of Houston, 9265 Kirby Dr., Houston, TX. NDC 42852-222-65
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Devices)·Z-2445-2018·2018-07-25

    NewDeal SA Recalls ADVANSYS MLP/DLP Medical Devices Due to Infection Risk

    NewDeal SA is recalling specific ADVANSYS MLP/DLP models because their use may cause superficial or deep infections requiring medical treatment.

    Product
    ADVANSYS MLP/DLP, Model Numbers: 181051S, 181052S, 181041S, 181042S, 181031S, 181032S, 181033S, 181021S, 181022S & 181023S
    Category
    Medical Device
    Distribution
    19 states
  • SevereFDA (Devices)·Z-2444-2018·2018-07-25

    NewDeal ADVANSYS TTC Medical Devices Recalled for Infection Risk

    NewDeal SA is recalling ADVANSYS TTC medical devices because they may cause superficial or deep infections requiring antibiotic treatment or device removal.

    Product
    ADVANSYS TTC, Model Numbers: 181011S, 181012S, 181013S, 181014S, 181001S, 181002S, 181003S & 181004S
    Category
    Medical Device
    Distribution
    19 states
  • HighFDA (Devices)·Z-2450-2018·2018-07-25

    Ethicon Recalls Certain Prolene Sutures Due to Packaging Design Issue

    Ethicon is recalling specific Prolene suture products because a packaging design issue allows needles to perforate the package, posing a risk of injury or infection.

    Product
    PROLENE SUTURE 4-36"(90CM) 4-0 BLUE, D5988
    Category
    Medical Device
    Distribution
    25 states
  • HighFDA (Devices)·Z-2456-2018·2018-07-25

    Ethicon Recalls Proline Sutures Due to Packaging Perforation Risk

    Ethicon is recalling 300 units of Proline Suture 30" 6-0 Blue because a packaging design issue may allow the needle to perforate the package, posing injury or infection risks.

    Product
    PROLENE SUTURE 30"(75CM) 6-0 BLUE, D8647
    Category
    Medical Device
    Distribution
    25 states
  • HighFDA (Devices)·Z-2461-2018·2018-07-25

    Ethicon Recalls Certain Prolene Sutures Due to Packaging Perforation Risk

    Ethicon is recalling specific Prolene suture products because a packaging design issue may allow needles to perforate the package, posing injury and infection risks.

    Product
    PROLENE SUTURE BLUE 48" 4-0 D/A SH-1, D9746
    Category
    Medical Device
    Distribution
    25 states
  • HighFDA (Devices)·Z-2466-2018·2018-07-25

    Ethicon Recalls Pronova Suture Due to Packaging Perforation Risk

    Ethicon is recalling 516 units of Pronova Suture Blue because the needle may perforate the packaging, posing a risk of soft tissue injury or infection.

    Product
    PRONOVA SUTURE BLUE 122CM M1.5, D10189
    Category
    Medical Device
    Distribution
    25 states
  • HighFDA (Devices)·Z-2457-2018·2018-07-25

    Ethicon Recalls Prolene Sutures Due to Packaging Perforation Risk

    Ethicon is recalling specific Prolene suture units because a packaging design issue allows needles to perforate the package, posing injury and infection risks.

    Product
    PROLENE SUTURE 24"(60CM) 6-0 BLUE, D8688
    Category
    Medical Device
    Distribution
    25 states
  • HighFDA (Devices)·Z-2451-2018·2018-07-25

    Ethicon Recalls Certain Prolene Sutures Due to Packaging Design Issue

    Ethicon, Inc. is recalling specific Prolene suture products because a packaging design issue allows the needle to perforate the package, posing a risk of injury or infection.

    Product
    PROLENE SUTURE 4-36" (90CM) 3-0 BLUE, D6416
    Category
    Medical Device
    Distribution
    25 states
  • HighFDA (Devices)·Z-2459-2018·2018-07-25

    Ethicon Recalls Certain Prolene Sutures Due to Packaging Design Issue

    Ethicon, Inc. is recalling specific Prolene suture products because a packaging design issue allows the needle to perforate the package, posing a risk of injury or infection.

    Product
    PROLENE SUTURE 36"(90CM) 4-0 BLUE, D9067
    Category
    Medical Device
    Distribution
    25 states